Three Venture Challenge teams selected for Biotech Booster 2025 cohort

We’re proud to share that three recent Venture Challenge teams have been selected for the Biotech Booster 2025 cohort:

• Lumox (Sebas Pronk)

• Detecting Parkinson (Françoise Dekker)

• Targeting RNA Dicing (Yuval Malka)

These teams exemplify the mission behind LifeSciences@Work: helping promising science grow into ventures that create real-world health impact. Their selection underscores both the quality of their propositions and the strength of the Dutch life sciences ecosystem.

Why this matters

• Visibility & validation: Biotech Booster supports ambitious projects with strong translational potential.

• Acceleration: Teams gain access to expert guidance, a broad partner network and targeted support to sharpen their development strategy.

• Impact focus: Projects address compelling needs—from novel oncology approaches to next-generation diagnostics and neurodegenerative disease insights.

About the programmes

Venture Challenge (LS@W) helps early-stage life sciences & health teams translate their research into a solid business case and investor-ready proposition.
Biotech Booster is a national initiative that accelerates high-potential biotech projects toward market and societal impact through expert support and a strong consortium network.

Source: LinkedIn